With regards to the captioned subject and in compliance with the SEBI (LODR) Regulation 2015 we wish to inform you that the Board of Directors of Neogen Chemicals Limited at its meeting held today i.e. Saturday, March 4, 2023 which commenced at 7.15 p.m. (IST) and concluded at 8.50 p.m.(IST), inter alia, considered and approved, the acquisition of 4,69,26,000 (100%) Equity Shares of a face value of Rs. 10 each, of BuLi Chemicals India Private Limited ('BuLi Chem') for an amount up to Rs. 25,00,00,000 approximately, subject to final working capital adjustments on closing date ('Acquisition'). Further, the Board of Directors of the Company has approved the draft of Share Purchase Agreement ('SPA') which was placed before them, for purchase of 100% equity shares of BuLi Chem from Livent USA Corporation and Livent Corporation ('Selling Shareholders') subject to the terms of SPA. Pursuant to the said transaction BuLi Chem will become a Wholly Owned Subsidiary of the Company.